<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.etp-nanomedicine.eu/public/test-news/RSS">
  <title>Featured News</title>
  <link>http://www.etp-nanomedicine.eu</link>
  
  <description>
    
       
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2009-01-20T09:27:21Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.etp-nanomedicine.eu/logo.jpg"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/get-insight-into-the-next-eu-framework-programme"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/new-market-research-report-nanotechnology-in-medical-applications-the-global-market"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/call-for-papers-and-posters-for-the-european-summit-for-clinical-nanomedicine-2012"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/nanofar-new-european-doctorate-in-nanomedicine-and-pharmaceutical-innovation"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/catalan-strategic-agenda-of-nanobiotechnology-published"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/breaking-down-barriers-to-research-2013-consultation-on-the-european-research-area"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/etpn-white-paper-on-improving-translation-of-public-healthcare-nano-research-in-europe"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/new-article-published-how-do-we-develop-nanopharmaceuticals-under-open-innovation"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/euminafab-5th-call-for-proposals"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/launch-of-the-bionanomed-catalunya-platform"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/report-on-european-perspectives-in-personalised-medicine"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/new-wind-on-regenerative-medicine-working-group"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/info-consultation-on-future-eu-research-and-innovation-funding-1"/>
        
        
            <rdf:li rdf:resource="http://www.etp-nanomedicine.eu/public/news-events/news/pfizer-uk"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/get-insight-into-the-next-eu-framework-programme">        <title>Get insight into the next EU Framework Programme</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/get-insight-into-the-next-eu-framework-programme</link>        <description>The European Commission elaborated a proposal for the next Framework Programme for Research and Innovation named Horizon 2020. Get key data, the main objectives and overview of the structure in the following presentation.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2012-01-26T15:27:48Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/new-market-research-report-nanotechnology-in-medical-applications-the-global-market">        <title>New market research report on Nanotechnology in Medical Applications</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/new-market-research-report-nanotechnology-in-medical-applications-the-global-market</link>        <description>The global nanomedicine market reached $63.8 billion in 2010 and $72.8 billion in 2011. The market is expected to grow to $130.9 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% between years 2011 and 2016. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2012-01-26T15:28:02Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/call-for-papers-and-posters-for-the-european-summit-for-clinical-nanomedicine-2012">        <title>Call for Papers and Posters for the European Summit for Clinical Nanomedicine 2012</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/call-for-papers-and-posters-for-the-european-summit-for-clinical-nanomedicine-2012</link>        <description>The call for Papers for the upcoming European Summit for Clinical Nanomedicine is open till 11th February 2012!</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2012-01-11T11:09:31Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/nanofar-new-european-doctorate-in-nanomedicine-and-pharmaceutical-innovation">        <title>NANOFAR: New European Doctorate in Nanomedicine and Pharmaceutical Innovation</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/nanofar-new-european-doctorate-in-nanomedicine-and-pharmaceutical-innovation</link>        <description>NANOFAR is a three-year PhD thesis in nanomedicine and pharmaceutical innovation, co-supervised by partners in two different countries and including a one-year mobility period.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-10-25T13:05:46Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/catalan-strategic-agenda-of-nanobiotechnology-published">        <title>Catalan Strategic Agenda of Nanobiotechnology published</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/catalan-strategic-agenda-of-nanobiotechnology-published</link>        <description>The IBEC-coordinated Connect-EU Nanobio + Nanomed Working Group has published a 'roadmap' for nanobiotechnology capabilities in Catalonia.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-10-25T10:10:43Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/breaking-down-barriers-to-research-2013-consultation-on-the-european-research-area">        <title>Breaking down barriers to research – consultation on the European Research Area</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/breaking-down-barriers-to-research-2013-consultation-on-the-european-research-area</link>        <description>The European Commission, DG Research and Innovation, launched on 13th September a public consultation on Breaking down barriers to research.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-09-16T07:24:34Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3">        <title>Nanobiotix Starts Clinical Trial with Lead Product NBTXR3</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/nanobiotix-starts-clinical-trial-with-lead-product-nbtxr3</link>        <description>Paris, France - September 13th 2011 - Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-09-14T08:10:04Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/etpn-white-paper-on-improving-translation-of-public-healthcare-nano-research-in-europe">        <title>ETPN White Paper on "Improving Translation of Public Healthcare Nano-Research in Europe" </title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/etpn-white-paper-on-improving-translation-of-public-healthcare-nano-research-in-europe</link>        <description>In this paper the ETP Nanomedicine together with the Nanomedicine community at large elaborates on the difficulties of translating research results in Nanomedicine from bench to bedside and from lab to products and provides four recommendations for actions to improve Nanomedicine research &amp; development in Europe.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-09-05T08:59:05Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/new-article-published-how-do-we-develop-nanopharmaceuticals-under-open-innovation">        <title>New article published: How do we develop nanopharmaceuticals under open innovation?</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/new-article-published-how-do-we-develop-nanopharmaceuticals-under-open-innovation</link>        <description>Following article from Mike Eaton has been published in the nanomedicine journal.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-09-01T13:41:46Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/euminafab-5th-call-for-proposals">        <title>EUMINAfab 5th Call for Proposals </title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/euminafab-5th-call-for-proposals</link>        <description>EUMINAfab: European Research Infrastructure for multimaterial micro and nano fabrication and characterization opens the 5th call for no fee access to 37 installations containing equipment to high end micro and nano technologies.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-09-01T06:58:38Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/launch-of-the-bionanomed-catalunya-platform">        <title>Launch of the BioNanoMed Catalunya Platform</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/launch-of-the-bionanomed-catalunya-platform</link>        <description>The first platform that connects Catalan groups, university, hospitals and corporate research in nanotechnology applied to health and biotechnology.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-05-17T11:27:36Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/report-on-european-perspectives-in-personalised-medicine">        <title>European Perspectives in Personalised Medicine</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/report-on-european-perspectives-in-personalised-medicine</link>        <description>The conference "European Perspectives in Personalised Medicine" took place on 12 -13 May 2011 in Brussels and gave substantial elements towards personalised medicine in Europe.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-05-18T07:39:55Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/new-wind-on-regenerative-medicine-working-group">        <title>New wind on the ETPN Working Group dedicated to Regenerative Medicine </title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/new-wind-on-regenerative-medicine-working-group</link>        <description>A new Chair as well as a new Vice-Chair has been elected to lead the RegMed WG</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-05-16T14:54:27Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/info-consultation-on-future-eu-research-and-innovation-funding-1">        <title>Info  Consultation on future EU Research and Innovation Funding </title>        <link>http://www.etp-nanomedicine.eu/public/info-consultation-on-future-eu-research-and-innovation-funding-1</link>        <description>Consultation: Green Paper on a Common Strategic Framework for future EU Research and Innovation Funding </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>sborrega</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press</dc:subject>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-02-18T14:04:11Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.etp-nanomedicine.eu/public/news-events/news/pfizer-uk">        <title>Pfizer plans to close an R&amp;D facility in the UK</title>        <link>http://www.etp-nanomedicine.eu/public/news-events/news/pfizer-uk</link>        <description>Article from www.pharmalot.com (1st Februar 2011). As part of its ongoing effort to brace for the loss of the Lipitor patent, Pfizer now plans to close an R&amp;D facility in Sandwick, Kent in the UK, which employs 2,400 jobs and was where Viagra was born. </description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>ngouze</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>News</dc:subject>                    <dc:subject>Featured</dc:subject>                    <dc:subject>Featured Internal</dc:subject>                <dc:date>2011-02-03T10:08:31Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>

